Cellectis S.A. ADR (CLLS)

HEALTH CARE: HEALTH CARE SUPPLIES
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

8 RUE DE LA CROIX JARRY PARIS, LLE-DE-FRANCE, FRANCE 75013

Cellectis produces proteins for therapeutic purposes, researches improvements in seed characteristics, and develops treatments against single-gene disorders and against infections by DNA viruses.

Data based on most recent fiscal year report
Market Cap764.949 Million Shares Outstanding42.45 Million Avg Volume163.733 Thousand
1-Yr BETA vs S&P TR1.724 Current Ratio10.4 Quick Ratio10.4
View SEC Filings from CLLS instead.

Funds Holding CLLS (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CLLS BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5
No current insider transactions
Click here to report any possible errors with this stock listing.

Elevate your investments